Constantine Davides

Q: What is Constantine Davides's success rate?

Constantine Davides currently has a success rate of 92.74963405196661.

Q: What is the average return of Constantine Davides's calls?

Their stock ratings have generated an average return of 20.620333738460264.

Citizens | Healthcare

Constantine Davides is an analyst from Citizens specializing in the Healthcare sector. Ranked #1141 out of 4773 analysts, they have issued 25 stock ratings with a success rate of 92.75% and an average return of 20.62%.

Constantine Davides has a well-established track record, with 25 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.75% and an average return of 20.62%, underscoring their expertise and ability to identify winning opportunities for investors.

#1141

Out of 4773

Total Ratings

+92.75%

Success Rate

+20.62%

Average Return

Recent Ratings Analysis

NRC

Buy

Jul 29, 2026

Target

$26.00

Current

$21.12

Performance

15.41%

Constantine Davides rated NRC as Market Outperform on Jul 29, 2026, setting a price target of 26. The call has proven timely, with shares rising 15.41% toward the price target of 26.

OMDA

Buy

Jul 20, 2026

Target

$27.00

Current

$19.66

Performance

-17.71%

On Jul 20, 2026, OMDA was given a Market Outperform rating by Constantine Davides, with a target price of 27. Despite the Buy call, shares fell from 19.66 to 19.66, challenging the optimistic stance.

USPH

Buy

Jun 24, 2026

Target

$98.00

Current

$78.72

Performance

18.89%

USPH received a Market Outperform rating from Constantine Davides on Jun 24, 2026, aiming for 98. Momentum has favored the Buy call, with shares climbing from 78.72 to 78.72, rewarding those who trusted the recommendation.

AMN

Buy

Jun 23, 2026

Target

$36.00

Current

$33.34

Performance

6.72%

On Jun 23, 2026, Constantine Davides published a Market Outperform outlook on AMN, with a target of 36. Shares gained 6.72%, underscoring the accuracy of the bullish outlook toward 36.

HQY

Buy

Jun 01, 2026

Target

$111.00

Current

$96.26

Performance

6.20%

Constantine Davides on Jun 01, 2026 assigned HQY a Market Outperform rating, with a price target of 111. The Buy call aligned well with market performance, producing a gain of 6.20%.

ADUS

Buy

May 18, 2026

Target

$142.00

Current

$117.09

Performance

26.39%

On May 18, 2026, Constantine Davides reaffirmed ADUS with a Market Outperform rating, targeting 142. The recommendation was supported by strong follow-through as the stock rose from 117.09 to 117.09.

PGNY

Buy

May 11, 2026

Target

$31.00

Current

$27.35

Performance

21.29%

PGNY was rated Market Outperform by Constantine Davides on May 11, 2026, with a price objective of 31. A bullish response from the market helped close the gap of 3.65 to the target.

OPCH

Buy

Jan 13, 2026

Target

$38.00

Current

$23.48

Performance

-32.43%

On Jan 13, 2026, Constantine Davides initiated coverage on OPCH with a Market Outperform rating and target of 38. The Buy call has yet to be validated as shares remain 14.52 away from the target.

EVH

Buy

Jan 06, 2026

Target

$11.00

Current

$4.19

Performance

4.23%

Constantine Davides issued a Market Outperform recommendation for EVH on Jan 06, 2026, price target set at 11. The target of 11 remains in play, though confirmation will depend on future moves.

PRVA

Buy

Nov 07, 2025

Target

$31.00

Current

$20.42

Performance

-12.85%

On Nov 07, 2025, PRVA was evaluated by Constantine Davides, who gave a Market Outperform rating and target of 31. Investors saw limited payoff as shares fell short of the 31 target.

OPRX

Buy

Nov 07, 2025

Target

$24.00

Current

$7.29

Performance

-53.42%

Constantine Davides rated OPRX as Market Outperform on Nov 07, 2025, setting a price target of 24. The stock has underperformed, dropping 53.42% despite the bullish target of 24.

WAY

Buy

Sep 18, 2025

Target

$48.00

Current

$23.47

Performance

-39.17%

On Sep 18, 2025, WAY was given a Market Outperform rating by Constantine Davides, with a target price of 48. Despite the Buy call, shares fell from 23.47 to 23.47, challenging the optimistic stance.

SLP

Hold

Jun 18, 2025

Target

—

Current

$18.42

Performance

1.88%

SLP received a Market Perform rating from Constantine Davides on Jun 18, 2025, aiming for null. Shares remained flat at 18.42, aligning with the neutral rating.

AMT

Buy

Feb 26, 2025

Target

$248.00

Current

$177.85

Performance

-11.40%

On Feb 26, 2025, Constantine Davides published a Market Outperform outlook on AMT, with a target of 248. Market action contradicted the Buy thesis, as shares slipped to 177.85.

AXGN

Buy

Feb 26, 2025

Target

$26.00

Current

$42.16

Performance

116.65%

Constantine Davides on Feb 26, 2025 assigned AXGN a Market Outperform rating, with a price target of 26. The Buy call aligned well with market performance, producing a gain of 116.65%.

AGL

Hold

Feb 26, 2025

Target

—

Current

$89.77

Performance

6.87%

On Feb 26, 2025, Constantine Davides reaffirmed AGL with a Market Perform rating, targeting null. Market strength beyond 89.77 went further than the conservative outlook suggested.

CCRN

Hold

Feb 06, 2025

Target

—

Current

$13.25

Performance

-27.20%

CCRN was rated Market Perform by Constantine Davides on Feb 06, 2025, with a price objective of null. Investors who stayed cautious avoided some of the 27.20% decline.

HSTM

Hold

Feb 06, 2025

Target

—

Current

$29.11

Performance

-11.92%

On Feb 06, 2025, Constantine Davides initiated coverage on HSTM with a Market Perform rating and target of null. The rating matched the stock’s inability to hold above 29.11.

CERT

Hold

Jul 10, 2024

Target

—

Current

$7.55

Performance

-45.61%

Constantine Davides issued a Market Perform recommendation for CERT on Jul 10, 2024, price target set at null. Market action validated the conservative Hold outlook with shares at 7.55.

Frequency Asked Questions

Who is Constantine Davides?

Constantine Davides is an analyst from Citizens specializing in the Healthcare sector.

What is Constantine Davides's success rate?

Constantine Davides currently has a success rate of +92.75%.

How many ratings has Constantine Davides issued?

Constantine Davides has issued 25 stock ratings so far.

What is the average return of Constantine Davides's calls?

Their stock ratings have generated an average return of +20.62%.

What is Constantine Davides's ranking?

Constantine Davides is ranked #1141 out of 4773 analysts.

What types of ratings does Constantine Davides give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Constantine Davides?

You can follow Constantine Davides by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Constantine Davides?

Their latest rating was a Buy on NRC issued on 2026-07-29.